Bibliography (15):

1. Glucagon, GLP-1 and Thermogenesis

2. Glucagon Regulation of Energy Expenditure

3. Glucagon increases energy expenditure independently of brown adipose tissue activation in humans

4. Unimolecular Polypharmacy for Treatment of Diabetes and Obesity

5. Safety and pharmacokinetics of single and multiple ascending doses of the novel oral human GLP-1 analogue, oral semaglutide, in healthy subjects and subjects with type 2 diabetes

6. An exercise-inducible metabolite that suppresses feeding and obesity

7. Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers

8. Wikipedia Bibliography:

   1. Glucagon-like peptide-1

   2. Glucose-dependent insulinotropic polypeptide

   3. https://en.wikipedia.org/wiki/Glucagon  :

      https://en.wikipedia.org/wiki/Glucagon

   4. https://en.wikipedia.org/wiki/Glucagon_receptor  :

      https://en.wikipedia.org/wiki/Glucagon_receptor

   5. https://en.wikipedia.org/wiki/Anorectic  :

      https://en.wikipedia.org/wiki/Anorectic

   6. https://en.wikipedia.org/wiki/Glycogenolysis  :

      https://en.wikipedia.org/wiki/Glycogenolysis

   7. Semaglutide

   8. https://en.wikipedia.org/wiki/Incretin  :

      https://en.wikipedia.org/wiki/Incretin